» Articles » PMID: 7719914

Dilution Assessment of Cervicovaginal Secretions Obtained by Vaginal Washing for Immunological Assays

Overview
Date 1995 Jan 1
PMID 7719914
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Local immunological defense mechanisms in the cervicovaginal mucosa currently remain incompletely defined, especially from a quantitative point of view. Addition of an inert substance, lithium chloride (LiCl), into the washing buffer used to carry out the vaginal washing for collecting cervicovaginal secretions and measurement of its concentration with a flame absorption spectrophotometer, before and after the specimen is sampled, permits the quantification of the volume of cervicovaginal secretions collected and the approximation of the dilution factor of a soluble component introduced by the washing. Lithium, at a concentration of 10 mM, gives the best precision of measurement and has no effect on the results of the immunoassays. In a population of 27 nonpregnant women (age range, 18 to 45 years), the volume of cervicovaginal secretions collected by vaginal washing with 3 ml of LiCl-phosphate-buffered saline was 12% +/- 3.2% (mean +/- standard deviation) of the total volume and showed large interindividual variations (range, 5.6 to 18.8%); the mean dilution factor of a soluble component from the vaginal secretions was 9.9% +/- 2.8% (range, 6.3 to 18.8%). According to the date of the menstrual cycle, the mean volume of collected cervicovaginal secretions was significantly increased in the luteal phase in comparison with the follicular phase; conversely, the mean dilution factor of a soluble component was more important in the follicular than in the luteal phase. These features strengthen the need to quantify accurately the dilution factor introduced by vaginal washing when studying cervicovaginal immunity.

Citing Articles

Vaginal irritation testing-prospects of human organotypic vaginal tissue culture models.

Ayehunie S, Landry T, Armento A In Vitro Cell Dev Biol Anim. 2024; 60(6):569-582.

PMID: 38995526 DOI: 10.1007/s11626-024-00907-1.


Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance.

Murphy D, Lim D, Armstrong R, McCoy C, Dallal Bashi Y, Boyd P Drug Deliv Transl Res. 2021; 13(8):2072-2082.

PMID: 34674162 PMC: 10315348. DOI: 10.1007/s13346-021-01081-7.


Passive immunization of the human vagina.

Anderson D Hum Vaccin Immunother. 2021; 18(2):1965423.

PMID: 34473605 PMC: 9103259. DOI: 10.1080/21645515.2021.1965423.


Surrogate post-coital testing for contraceptive efficacy against human sperm activity in the ovine vaginal model†.

Zhu Y, Saada J, Bhawana S, Lai S, Villarreal P, Pyles R Biol Reprod. 2020; 104(2):317-324.

PMID: 33300559 PMC: 7876660. DOI: 10.1093/biolre/ioaa221.


Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination.

Mboumba Bouassa R, Pere H, Gubavu C, Prazuck T, Jenabian M, Veyer D PLoS One. 2020; 15(5):e0233084.

PMID: 32421735 PMC: 7233543. DOI: 10.1371/journal.pone.0233084.


References
1.
Belec L, Georges A, Steenman G, Martin P . Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis. 1989; 160(3):385-91. DOI: 10.1093/infdis/160.3.385. View

2.
Thongcharoen P, Wasi C, Louisirirotchanakul S, Parry J, Connell J, Mortimer P . Immunoglobulin G antibody capture enzyme-linked immunosorbent assay: a versatile assay for detection of anti-human immunodeficiency virus type 1 and 2 antibodies in body fluids. J Clin Microbiol. 1992; 30(12):3288-9. PMC: 270653. DOI: 10.1128/jcm.30.12.3288-3289.1992. View

3.
Virolainen A, Makela M, Esko E, Jero J, Alfthan G, Sundvall J . New method to assess dilution of secretions for immunological and microbiological assays. J Clin Microbiol. 1993; 31(5):1382-4. PMC: 262946. DOI: 10.1128/jcm.31.5.1382-1384.1993. View

4.
Lu X, Belec L, Pillot J . Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J Infect Dis. 1993; 167(5):1189-92. DOI: 10.1093/infdis/167.5.1189. View

5.
Lehner T, Bergmeier L, Panagiotidi C, Tao L, Brookes R, Klavinskis L . Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science. 1992; 258(5086):1365-9. DOI: 10.1126/science.1360702. View